Form 8-K - Current report:
SEC Accession No. 0001193125-22-221350
Filing Date
2022-08-15
Accepted
2022-08-15 17:53:29
Documents
13
Period of Report
2022-08-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d376725d8k.htm   iXBRL 8-K 52824
2 EX-10.1 d376725dex101.htm EX-10.1 98460
  Complete submission text file 0001193125-22-221350.txt   301063

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wve-20220809.xsd EX-101.SCH 2882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20220809_lab.xml EX-101.LAB 17928
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20220809_pre.xml EX-101.PRE 11256
7 EXTRACTED XBRL INSTANCE DOCUMENT d376725d8k_htm.xml XML 3326
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 221167235
SIC: 2834 Pharmaceutical Preparations